NGM Biopharmaceuticals Inc
Pharmaceutical company · South San Francisco, California, United States
NGM Biopharmaceuticals Inc is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2007. It has reported private securities offerings to the US SEC, most recently $106 million sold in a notice filed in 2015.
NGM Biopharmaceuticals at a glance
What does NGM Biopharmaceuticals do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $106 million sold (2015).
Frequently asked questions about NGM Biopharmaceuticals
Where is NGM Biopharmaceuticals headquartered?
NGM Biopharmaceuticals Inc is headquartered in South San Francisco, California, United States.
What does NGM Biopharmaceuticals do?
NGM Biopharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was NGM Biopharmaceuticals founded?
The earliest incorporation on record for NGM Biopharmaceuticals Inc is in 2007, according to public company registers.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences